RelatedLinks

June 27th

June 26th

June 25th

June 20th

June 18th

June 6th

  • New breast cancer drug class stars at ASCO - FierceBiotech: In one trial, Sanofi Aventis reported that BSI-201 in combination with chemotherapy extended average survival times by three and a half months, to 9.2 months. That study involved 116 women whose triple-negativ e breast cancer had metastasized. And in a non-randomized study involving 52 women with BRCA1 and BRCA2 mutations, AstraZeneca� 39;s olaparib spurred tumor shrinkage that reached up to 41 percent.

June 2nd

May 22nd

  • INTELLECTUAL "PROPERTY": How human genes become patented - 20% of all human genes now patented: I've been against this since the 1980s. It's sickening that people will die of breast cancer because they can't afford to pay royalties on a diagnoses method that isn't priced at a free market value because they've patented the testing of certain genes. Our genetics belong to all of us. Life should not be patentable. Yet another failing of intellectual "property " -- the idea that if you have an idea first, or observe a gene first -- that you "own" ; it. What self-serving capitalistic b.s. It holds us all back. People die so that someone else can get rich. Originally from CNN: http://www.cnn .com/2009/HEAL TH/05/13/genes .patent.myriad /
  • Current progress in the BRCA1 project: The 185delAG mutation is documented to be the most prevalent type of BRCA1 mutation

May 19th

    Video Buzz > BRCA1

    Format: AVI | MPEG | Real | Quicktime | Window Media

    No Matching Video

    No video for BRCA1 is available at this time.

    Related BRCA1 News

    Newly developed drug treats cancer cells - Presstv

    A new drug has shown promising results in treating breast, ovarian and prostate cancers in individuals who inherited mutated BRCA1 and BRCA2 genes. BRCA mutations in tumor cells disable the pathways responsible for repairing DNA damage in the ...

    New cancer drug shows promise - Tehran Times

    ?It?s giving patients who have already tried many conventional treatments long periods of remission, free from the symptoms of cancer or major side-effects.? Olaparib is the first successful example of a new type of personalized medicine using ...

    Courage, determination, survival are on display at Relay for Life - Herald-Palladium

    BERRIEN SPRINGS - Tales of courage, survival and determination abound at this weekend's Relay for Life event at the Berrien County Youth Fairgrounds. Two of those stories belong to Estela Miser and Denise Bohn Stewart. Last year, both women got the ...

    BRCA1 Podcasts

    Do you prefer to listen to your brca1 gossip? Check out Podzy Podcast Directory > BRCA1.

    BRCA1 Products

    Looking for brca1 related products, then look no further. Try our new BRCA1 Shop.


    Powered by Odin Assemble